Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ZAYNICH safely and effectively. See full prescribing information for ZAYNICH. ZAYNICH (cefepime and zidebactam) for injection, for intravenous use Initial U.S. Approval: 2026
Medication labelWhy this: Advisory · dailymed-prescription
ZAYNICH is indicated for the treatment of adult patients with complicated urinary tract infections (cUTI) including pyelonephritis caused by the following susceptible microorganisms: Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Enterobacter cloacaecomplex, and Pseudomonas aeruginosa. To reduce the development of drug-resistant bacteria and maintain the effectiveness of ZAYNICH and other antibacterial drugs, ZAYNICH should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
- generic_name
- zidebactam dihydrate and cefepime hydrochloride
- product_names
- zidebactam dihydrate and cefepime hydrochloride
- ndc
- 87706-866, 87706-866-00, 87706-866-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en